11:09 AM EDT, 09/03/2025 (MT Newswires) -- Nanalysis Scientific ( NSCIF ) on Wednesday said it signed a "multi-pronged" five-year OEM supplier and technology licensing agreement with IMRIS, which delivers MRI and imaging data to clinicians

The agreement includes an undisclosed upfront payment and builds on a prior contract completed over the last 12 months, a statement said.

Nanalysis develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers used in pharma, biotech, energy, food, materials, and security industries, and in academic and government labs.

"The non-exclusive agreement we are announcing provides some immediate cash and some larger, medium-term revenue potential," said Chief Executive Officer Sean Krakiwsky. "The core electronics and software being licensed are also used in our benchtop NMR and high-field NMR products, which are sold around the world."

The company's shares were last seen up $0.01 to $0.21 on the TSX Venture Exchange.

Price: 0.21, Change: +0.01, Percent Change: +5.13